← all works
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Gastroenterology
- Topic
- Inflammatory Bowel Disease
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- University of CalgarySt. Paul's HospitalUniversity of British Columbia
- Funders
- —
- Keywords
- AdalimumabMedicinePlaceboInternal medicineCrohn's diseaseAdverse effectRandomized controlled trialGastroenterologyTumor necrosis factor alphaDiseasePathology
- Has abstract in OpenAlex
- no